We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Atnahs Pharma UK Limited have identified missing information on the PIL of the above batches.
Decisions made by The MHRA following investigations into complaints about advertising for licensed medicines.
An England-wide survey of over 5,000 adults found that 80% of people aged over 18 have made the decision to change their lifestyle in 2021.
First published during the 2015 to 2016 Cameron Conservative government
Food industry encouraged to help people move towards and maintain a healthier weight by reducing excessive calories in everyday foods by up to 20% by 2024.
Employment Tribunal decision.
Details of seizure notice served as part of an investigation by Defra Investigation Services (DIS) on Working Dog Foods in October 2022.
Boots have identified an error with the printed patient information leaflet provided with batches of the Decongestant Tablets and Decongestant with Pain Relief Tablets.
A summary of recent letters, medicine recalls and notifications sent to healthcare professionals.
Pilot scheme will motivate people to make healthy changes to their lifestyle.
First published during the 2019 to 2022 Johnson Conservative government
ADVANZ PHARMA has made the MHRA aware that certain batches of MacroBID 100mg Prolonged-Release Capsules have been packed with the incorrect Patient Information Leaflet (PIL).
A personal trainer was sentenced today to 31 months in jail for selling and supplying unlicensed and prescription medicines, together with Anabolic steroids, to the public.
Health supplements boss who failed to rein in aggressive overseas call centre banned for nine years.
Prescribers and dispensers should use caution if switching patients between different long-acting formulations of methylphenidate (Concerta XL, Medikinet XL, Equasym XL, Ritalin LA, and generics) as different instructions for use and different release profiles may affect symptom management.
Folic acid will be added to non-wholemeal wheat flour across the UK to help prevent life-threatening spinal conditions in babies.
Galderma (U.K.) Limited has informed the MHRA that the Patient Information Leaflet (PIL) packaged in some batches of Epiduo 0.1% / 2.5% gel contain outdated safety information regarding pregnancy.
A recent Europe-wide review of the safety information for alli has led to a number of updates, which bring the product information in line with that for Xenical.
Evidence indicates risks outweigh benefits.
Aspar Pharmaceuticals Limited has informed us that the Patient Information Leaflets (PILs) within the ibuprofen packs below are missing some information identified from post-marketing experience that should be documented in Section 3 (How To Take The Tablets) and Section 4...
Ratiopharm UK Limited and Generics [UK] Limited t/a Mylan have confirmed that the Patient Information Leaflet (PIL) within all packs and the Summary of Product Characteristics (SmPC) for Ratiopharm is missing important safety information related to potential suicide risks
Decisions made by MHRA following investigations into complaints about advertising for licensed medicines.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).